FR3043M - Medicinal product based on a new series of 1-aryl-4-oxo-1,3,8-triazaspiro- (4,5) -decanes, substituted in position 8 or their salts for the treatment of mental disorders. - Google Patents

Medicinal product based on a new series of 1-aryl-4-oxo-1,3,8-triazaspiro- (4,5) -decanes, substituted in position 8 or their salts for the treatment of mental disorders.

Info

Publication number
FR3043M
FR3043M FR948240A FR948240A FR3043M FR 3043 M FR3043 M FR 3043M FR 948240 A FR948240 A FR 948240A FR 948240 A FR948240 A FR 948240A FR 3043 M FR3043 M FR 3043M
Authority
FR
France
Prior art keywords
decanes
triazaspiro
oxo
aryl
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR948240A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of FR3043M publication Critical patent/FR3043M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Wire Processing (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR948240A 1962-06-22 1963-09-20 Medicinal product based on a new series of 1-aryl-4-oxo-1,3,8-triazaspiro- (4,5) -decanes, substituted in position 8 or their salts for the treatment of mental disorders. Active FR3043M (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20462362A 1962-06-22 1962-06-22
FR939044 1963-06-22

Publications (1)

Publication Number Publication Date
FR3043M true FR3043M (en) 1965-01-04

Family

ID=22758700

Family Applications (6)

Application Number Title Priority Date Filing Date
FR1573808D Expired FR1573808A (en) 1962-06-22 1963-06-22
FR948244A Active FR3059M (en) 1962-06-22 1963-09-20 Medicinal product for the treatment of mental and cardiovascular disorders containing a new series of 1-phenyl-4-oxo-1,3,8-triazaspiro- [4,5] -decanes or their salts.
FR948240A Active FR3043M (en) 1962-06-22 1963-09-20 Medicinal product based on a new series of 1-aryl-4-oxo-1,3,8-triazaspiro- (4,5) -decanes, substituted in position 8 or their salts for the treatment of mental disorders.
FR948243A Active FR2988M (en) 1962-06-22 1963-09-20 Drug for the treatment of mental illnesses and for combating pain, based on a new series of 1-phenyl-4-oxo-8- (aryl-pentenyl) -1,3,8-triazaspiro (4,5) decanes.
FR948242A Active FR2987M (en) 1962-06-22 1963-09-20 Medicinal product based on a new series of 8- [2- (1,4-benzodioxannyl) -methyl] -1,3,8-triazaspiro (4,5) decanes, as well as their salts.
FR948241A Active FR2986M (en) 1962-06-22 1963-09-20 Medicinal product based on new 1-aryl-4-oxo-8-aralkyl-1,3,8-triazaspiro (4,5) decanes, as well as their salts with analgesic action.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
FR1573808D Expired FR1573808A (en) 1962-06-22 1963-06-22
FR948244A Active FR3059M (en) 1962-06-22 1963-09-20 Medicinal product for the treatment of mental and cardiovascular disorders containing a new series of 1-phenyl-4-oxo-1,3,8-triazaspiro- [4,5] -decanes or their salts.

Family Applications After (3)

Application Number Title Priority Date Filing Date
FR948243A Active FR2988M (en) 1962-06-22 1963-09-20 Drug for the treatment of mental illnesses and for combating pain, based on a new series of 1-phenyl-4-oxo-8- (aryl-pentenyl) -1,3,8-triazaspiro (4,5) decanes.
FR948242A Active FR2987M (en) 1962-06-22 1963-09-20 Medicinal product based on a new series of 8- [2- (1,4-benzodioxannyl) -methyl] -1,3,8-triazaspiro (4,5) decanes, as well as their salts.
FR948241A Active FR2986M (en) 1962-06-22 1963-09-20 Medicinal product based on new 1-aryl-4-oxo-8-aralkyl-1,3,8-triazaspiro (4,5) decanes, as well as their salts with analgesic action.

Country Status (9)

Country Link
BE (1) BE633914A (en)
CH (1) CH462835A (en)
DE (1) DE1470125C3 (en)
DK (1) DK119880B (en)
FI (1) FI46967C (en)
FR (6) FR1573808A (en)
GB (1) GB1043141A (en)
NO (1) NO117368B (en)
SE (1) SE311019B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080328A (en) * 1971-07-13 1978-03-21 Sumitomo Chemical Company, Limited N-substituted heterocyclic derivatives and preparation thereof
BE792187A (en) * 1971-12-03 1973-03-30 Sumitomo Chemical Co NEW ALKYLAMINE DERIVATIVES
US4066772A (en) * 1975-07-21 1978-01-03 Janssen Pharmaceutica N.V. 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
NZ181256A (en) * 1975-07-21 1978-04-28 Janssen Pharmaceutica Nv 1-(w-benzazol-11-ylalkyl)-piperidine derivatives and pharmaceutical compositions containing certain of these derivatives
DK139684A (en) * 1983-04-11 1984-10-12 Janssen Pharmaceutica Nv N-aryl-alpha-amino carboxamides
US5703088A (en) * 1989-08-21 1997-12-30 Beth Israel Deaconess Medical Center, Inc. Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5244902A (en) * 1989-08-21 1993-09-14 Beth Israel Hospital Association Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5574041A (en) * 1990-03-16 1996-11-12 Beth Israel Hospital Association Use of spiperone derivatives as immunosuppressant agents
US5693645A (en) * 1992-12-23 1997-12-02 Beth Israel Deaconess Medical Center, Inc. Use of spiperone or spiperone derivatives as immunosuppressant agents
DE19610397A1 (en) * 1996-03-16 1997-09-18 Krewel Meuselbach Gmbh Production of fluspirilene suspensions
WO1999059997A1 (en) * 1998-05-18 1999-11-25 Novo Nordisk A/S Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
US6277991B1 (en) 1998-05-18 2001-08-21 Novo Nordisk A/S 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
EP0997464B1 (en) * 1998-10-23 2005-02-16 Pfizer Inc. 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists
US7459461B2 (en) 2001-10-19 2008-12-02 Ortho-Mcneil Pharmaceutical, Inc. Phosphonic acid compounds as inhibitors of serine proteases
DE102005038141A1 (en) * 2005-08-12 2007-02-15 Grünenthal GmbH Substituted 8- (3-aminopropyl) -1-phenyl-1,3,8-triaza-spiro [4.5] decan-4-one derivatives
MX2012014470A (en) * 2010-06-18 2013-06-13 Altos Therapeutics Llc D2 antagonists, methods of synthesis and methods of use.
IT201800007580A1 (en) * 2018-07-27 2020-01-27 Maria Cecilia Hospital Spa 1,3,8-triazaspiro compounds and their use as medicaments

Also Published As

Publication number Publication date
DE1470125C3 (en) 1980-07-10
FI46967C (en) 1973-08-10
FR2986M (en) 1964-12-07
FR1573808A (en) 1969-07-11
FR2988M (en) 1964-12-07
FR3059M (en) 1965-01-11
CH462835A (en) 1968-09-30
DK119880B (en) 1971-03-08
FI46967B (en) 1973-05-02
NO117368B (en) 1969-08-04
FR2987M (en) 1964-12-07
GB1043141A (en) 1966-09-21
SE311019B (en) 1969-05-27
BE633914A (en)
DE1470125B2 (en) 1979-10-31
DE1470125A1 (en) 1969-05-08

Similar Documents

Publication Publication Date Title
FR3043M (en) Medicinal product based on a new series of 1-aryl-4-oxo-1,3,8-triazaspiro- (4,5) -decanes, substituted in position 8 or their salts for the treatment of mental disorders.
FR2427M (en) Bacteriotherapeutic drug, in particular for the treatment of gastrointestinal disorders.
FR3069M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR2984M (en) Medicinal product for the treatment of cardiovascular disorders based on dl-4- (acetyl-aminomethyl) -1- [2- (1,4-benzodioxanyl) -methyl] -4-phenylpiperidine.
FR1215M (en) New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenia.
FR3672M (en) Medicinal product based on nicotinic acid derivatives for the treatment of circulatory disorders.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR3845M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR2739M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR3066M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR2576M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR3153M (en) Drug for the treatment of coronary heart disease, based on isopropylidene-2 ', 3' adenosine.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3697M (en) Medicines based on novel heterocyclic compounds for the treatment of coronary artery disease.
FR2683M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR3532M (en) New drug, in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR2940M (en) Medicinal product for the treatment of arterial disease based on glyoxylic acid.
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR1703M (en) Medicinal product based on a basic derivative of butynol, in particular for the treatment of gastrointestinal disorders.
FR2656M (en) New drug, in particular for the treatment of chronic or postprandial hyperlipemia.
FR3269M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR2913M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR3598M (en) Medicinal product for the treatment of people suffering from poor absorption of fat.
FR1904M (en) Drug based on n-acyl-hydroxyamino-acetic acid for the treatment of tumors.